cjc-1295 ipamorelin cancer risk Ipamorelin, and Cancer: Is There Any Evidence? ipamorelin and cancer Largest study

Your liver is the primary detoxification organ, and glutathione is critical for its Phase II detox pathways

Common, usually mild: Injection-site reactions (redness, swelling, itching), most frequent with both Mild headache, dizziness, or flushing after injection Initial water retention as IGF-1 rises Transient fatigue in the first 12 weeks Less common, dose-dependent: Carpal tunnel-like wrist symptoms (sign IGF-1 may be too high) Joint discomfort or stiffness Numbness or tingling in extremities Elevated blood glucose (GH antagonizes insulin) The monitoring that matters:IGF-1 (insulin-like growth factor 1, the downstream marker of GH activity) is the lab value that tells you whether youre in a therapeutic range or pushing past it

References Muccioli, Giampiero, et al

This process, known as hyperplasia, leads to the creation of new muscle fibers and increased muscle cell numbers, contributing to long-term growth potential